Ignite Creation Date:
2024-05-06 @ 12:57 PM
Last Modification Date:
2024-10-26 @ 1:07 PM
Study NCT ID:
NCT03896945
Status:
TERMINATED
Last Update Posted:
2024-05-24
First Post:
2019-03-19
Brief Title:
Efficacy Safety and Tolerability of AVP-786 for the Treatment of Negative Symptoms of Schizophrenia
Sponsor:
Otsuka Pharmaceutical Development Commercialization Inc
Organization:
Otsuka Pharmaceutical Development Commercialization Inc